Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
fda
8
×
life sciences
8
×
national blog main
biotech
national top stories
boston blog main
new york blog main
new york top stories
boston top stories
clinical trials
startups
food and drug administration
new york
novartis
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
boston
johnson & johnson
medical devices
raleigh-durham blog main
san diego blog main
san diego top stories
sanofi
wisconsin blog main
wisconsin top stories
abbvie
achromatopsia
akouos
alex gorsky
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
amyotrophic lateral sclerosis (als)
anirvan ghosh
ashley mcevoy
What
deal
8
×
drug
medicines
startup
acquire
biggest
billion
cash
developer
disease
johnson
medical
plans
therapy
years
acquiring
acquisitions
adding
age
agreed
alternative
announced
appear
atrial
auris
autoimmune
bigger
bio
boston
brings
building
builds
business
buy
candidate
ceo
cholesterol
collabs
come
companies
Language
unset
Current search:
deal
×
fda
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed